Thomas and Andreas Struengmann, who were seed investors in BioNTech, are still its biggest shareholders with a roughly 43% stake, for now. Read More
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
Subscribe now to keep reading and get access to the full archive.